Research

Malaria control is a work in progress. Various organizations conduct research and development (R&D;) for new insecticides, new drugs and an effective vaccine. In addition to existing malaria control Commodity Manufacturers, these include but are not limited to:

Innovative Vector Control Consortium (IVCC)
Medicines for Malaria Venture (MMV)
Malaria Vaccine Initiative (MVI)
Multilateral Initiative on Malaria (MIM)

Global funding for malaria control R&D; was approximately $323 million in 2004. This figure has likely increased considerably with contributions from the Gates Foundation. The development of new malaria control tools must be carefully balanced with efforts to save lives with effective tools available today, like Long-Lasting Insecticidal Nets and Artemisinin-based Combination Therapy. Research must also go hand-in-hand with better policies to ensure both existing and new tools reach the poorest and most vulnerable to malaria.

Must Read Inconclusive study on DDT has potentially mortal consequences May 15, 2023 Ghana: Mal 47 Malaria Vaccine Trial - So Far So Good December 14, 2023 Malaria Keeps Killing Millions May 16, 2023 Certain Combination Therapy Found More Effective For Treating Malaria In African Children May 28, 2023 Pro-malaria forces resurface at WHO May 16, 2023	AFM Articles Time for African leaders to take malaria seriously July 22, 2023 Precaution and funding of vector control must be based on evidence May 18, 2023 AFM Observations on the 5th Conference of Parties of the Stockholm Convention April 29, 2023 False reporting and the fight against malaria February 08, 2024 AFM Bulletin #6: Recognizing the way insecticides work in malaria control - the critical importance of WHO's position on DDT January 31, 2024 » more...	News Potential Malaria Vaccine Protects Against Different Strains July 29, 2023 Wilson To's Malaria Test July 28, 2023 Scientists: Stinky sock smell helps fight malaria July 13, 2023 Malaria Parasites Use Camouflage to Trick Immune Defences of Pregnant Women July 12, 2023 New hope for malaria July 06, 2023 » more...
Research Malaria in Kakuma refugee camp, Turkana, Kenya: facilitation of Anopheles arabiensis vector populations by installed water distribution and catchment systems June 06, 2023 Paracetamol versus placebo in treatment of non-severe malaria in children in Guinea-Bissau: a randomized controlled trial June 04, 2023 From quinine to artesunate in Africa May 26, 2023 The initial pharmaceutical development of an artesunate/amodiaquine oral formulation for the treatment of malaria: a public-private partnership May 23, 2023 Trends in malaria research in 11 Asian Pacific countries: an analysis of peer-reviewed publications over two decades May 18, 2023 » more...	Press Releases Uganda: First vaccination for GMZ2 malaria vaccine trial May 09, 2023 Bayer CropScience signs research agreement with IVCC May 14, 2023 DNDi Partners With Pharma, Biotech, Academia, Public Health Institutes & NGOs to Deliver Lifesaving Drugs June 24, 2023 DDT Highly Effective Against Resistant Mosquitoes August 09, 2023 Scientists discover new compound that kills drug-resistant malaria February 12, 2024 » more...	Events Capitol Hill Policy Briefing: Public Health Insecticides and Integrated Vector Control June 18, 2023 ASTMH Annual Meeting November 04, 2023 Fifth AMANET Biennial Conference February 26, 2024